Phase II Trial of Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Enzalutamide (Primary) ; Fulvestrant (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Jun 2017 Status changed from not yet recruiting to recruiting.
- 10 Jun 2017 Biomarkers information updated
- 23 Mar 2017 Planned initiation date changed from 1 Jan 2017 to 1 Apr 2017.